Skip to content

BRKRP

BRUKER CORP

NASDAQ · Healthcare · Medical - Devices · US

$410.61
+1.17%
Ask drillr

Year over year

Reported trailing growth

Revenue
+1.6%
EBITDA
-38.6%
EBIT
-31.2%
EPS
—
Free cash flow
+90.5%
Operating cash flow
+14.8%

Forward estimates

Based on analyst estimates

Revenue
+4.4%
EBITDA
+193.9%
EPS
+441.7%

Three-year CAGR

Revenue
+10.7%
EBITDA
-16.4%
EBIT
-18.3%
Net income
—
EPS
—
Free cash flow
-54.3%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026